<SEC-DOCUMENT>0001193125-17-217873.txt : 20170629
<SEC-HEADER>0001193125-17-217873.hdr.sgml : 20170629
<ACCEPTANCE-DATETIME>20170629124132
ACCESSION NUMBER:		0001193125-17-217873
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20170629
DATE AS OF CHANGE:		20170629
EFFECTIVENESS DATE:		20170629

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Galena Biopharma, Inc.
		CENTRAL INDEX KEY:			0001390478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33958
		FILM NUMBER:		17937554

	BUSINESS ADDRESS:	
		STREET 1:		4640 SW MACADAM AVENUE
		STREET 2:		SUITE 270
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97239
		BUSINESS PHONE:		855 855 GALE

	MAIL ADDRESS:	
		STREET 1:		4640 SW MACADAM AVENUE
		STREET 2:		SUITE 270
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97239

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RXi Pharmaceuticals Corp
		DATE OF NAME CHANGE:	20110926

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GALENA BIOPHARMA, INC.
		DATE OF NAME CHANGE:	20110922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RXI PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20110921
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d404112ddefa14a.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Additional Materials</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Under Rule 14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>GALENA BIOPHARMA,
INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g404112img2.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">105 Madison Avenue, New York, NY, 10016</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-929-5500</FONT></FONT> Fax: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">212-929-0308</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: proxy@mackenziepartners.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Please Contact MacKenzie Partners <U>Today</U> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Vote Your Shares! </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;29, 2017
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholder: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Special Meeting of Stockholders
(&#147;Special Meeting&#148;) of Galena Biopharma, Inc. (&#147;Galena&#148;), scheduled to be held on July&nbsp;6, 2017, is now less than a week away. We at MacKenzie Partners are contacting you as Galena&#146;s proxy solicitor. We have been engaged
to assist in gathering the votes for this very important Special Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As explained in the proxy statement (&#147;Proxy Statement&#148;) that was
previously delivered to all stockholders and the letter accompanying this mailing, voting against the proposals set forth in the Proxy Statement may, among other things, prevent the Company from completing a strategic transaction and consequently,
could result in forcing the Company to file for bankruptcy or an involuntary petition for bankruptcy being filed against the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No matter how many
shares you hold, your vote is very important. We encourage you to have your voice heard in this important decision regarding your investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are
standing by to assist you in quickly and easily voting your shares by phone today, please contact MacKenzie Partners at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+&nbsp;1-212-929-5500</FONT></FONT></FONT> (call collect) or toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-322-2885</FONT></FONT></FONT> (in North America.). You may also send your voting instructions via email to: proxy@mackenziepartners.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Voting will only take a few minutes of your time, but can help save Galena the additional expense of further outreach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>MacKenzie Partners, Inc. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Call Collect at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-212-929-5500</FONT></FONT></FONT> or </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Toll-Free (in North America) at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-322-2885</FONT></FONT></FONT> </B></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g404112img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g404112img2.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MZY^%?QVTOP%^QEX0^(?Q4U:1X+7PS!/=W$SYDNY0@ 49^\[-P!ZF@#Z-$@)
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M=/N;CG/F7+H3,Q]]^:^N]"^)/B/]N+PI\.?@)\)Y[JQ\):/HEHWC[6PI48C
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M*[G8M@^F: .D_8 ^!GQ:^+_CCQ'X_P#A!XJTWPMJ6CNR3:MJ5L;@2S7 )95
M_B(SD^]?K5^S3\/_ (M>"=/U<_M >.[/QI>74L?]GBTL_(2VC4$-GU+$C\J^
M!_V*?VJ?^&9?A78^"1\$OB/J.KWM^\U_?PV9C21Y& 7[RYPH Z^]?JMHEX^H
MZ;;74]N]I+<0I(]N[!C$2,[21U(H OT444 4M6U.WT>PN;W4'$5M9P/--(?X
M44$M^@KXK_X)]P7'Q/\ &/Q:^..K*6?QEKSZ?I#M_P L[.W.T >QX/XUVO\
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MC^*/$&L^&Y[S2M4D-G;+>1DI=Z<F!$()<<$*!P#0!^K7P!^/^F_'6PUN73M
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$@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
